Ambrx Biopharma, Inc. - Common Stock (NY:AMAM)

N/A UNCHANGED

Last Price Updated: 7:00 PM EDT, Mar 16, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ambrx Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 24, 2023

Via Benzinga

Analyst Ratings for Ambrx Biopharma ↗

October 23, 2023

Via Benzinga

Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 23, 2023

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.

Via Benzinga

Why Shares of Ambrx Biopharma Soared This Week ↗

September 21, 2023

A big buy by an asset manager spurred interest in the biotech stock.

Via The Motley Fool

Where Ambrx Biopharma Stands With Analysts ↗

September 13, 2023

Via Benzinga

Expert Ratings for Ambrx Biopharma ↗

June 14, 2023

Via Benzinga

FMC, Li-Cycle Holdings, Okta And Other Big Stocks Moving Lower On Monday ↗

October 23, 2023

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 23, 2023

Via Benzinga

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.

Via Benzinga

Why Vistagen Therapeutics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares surged 79.5% to $5.08 in pre-market trading after falling around 7% on Monday. SciSparc recently regained compliance with the Nasdaq Minimum Bid Price...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

October 17, 2023

It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday!

Via InvestorPlace

NetScout Systems, Ericsson And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

October 17, 2023

U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 16, 2023

Via Benzinga

Cancer Focused Ambrx Biopharma Stock Trading Lower Today - Here's Why ↗

October 16, 2023

Ambrx Biopharma Inc (NASDAQ: AMAM) announced that two abstracts detailing updated safety and efficacy data from the ongoing Phase 1/2 trial, APEX-01, evaluating ARX517 for metastatic...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 16, 2023

Via Benzinga

Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 16, 2023

Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.

Via Benzinga

Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket ↗

October 16, 2023

Gainers LQR House Inc. (NASDAQ: LQR) shares surged 109% to $0.3602 in pre-market trading after the company delivered inaugural order to Costco, securing Von Payne Whiskey's presence on store shelves.

Via Benzinga

Domino's, Walgreens, Fastenal And Other Big Stocks Moving Higher On Thursday ↗

October 12, 2023

U.S. stocks traded mixed, with the Dow Jones falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023 ↗

September 25, 2023

Via Benzinga

Around $19M Bet On Westrock Coffee? Check Out These 3 Stocks Insiders Are Buying ↗

September 20, 2023

Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 15, 2023

Via Benzinga

PTC Therapeutics, Planet Fitness, Kemper And Other Big Stocks Moving Lower On Friday ↗

September 15, 2023

U.S. stocks traded higher, with the Dow Jones falling around 180 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

Ambrx Biopharma Has Surged 483% This Year. But It Could Just Be Getting Started. ↗

August 31, 2023

The company has another update on its prostate cancer program that could further prod shares.

Via Investor's Business Daily

Unique ADC Constructs Boost Ambrx Biopharma's Profile: Analyst Sees Optimistic Outlook ↗

July 31, 2023

RBC Capital Markets initiated coverage on Ambrx Biopharma Inc (NASDAQ: AMAM) With an Outperform rating and a

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023 ↗

September 12, 2023

Via Benzinga

Investor Opportunities Ahead of Clinical Updates, Says Analyst Initiating Coverage on Ambrx Biopharma with 'Buy' Rating ↗

June 14, 2023

B Riley Securities has initiated Ambrx Biopharma Inc (NASDAQ: AMAM) with a Buy rating and a

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023 ↗

June 02, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023 ↗

July 31, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 ↗

June 14, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.